$15 – $20

Dr. Fleisher: Medication-Related Osteonecrosis of the Jaw Update

Event Information

Share this event

Date and Time

Location

Location

NYU College of Dentistry

345 East 24th Street

Room 11CF

New York, NY 10010

View Map

Friends Who Are Going
Event description

Description

Bone health and maintenance of bone integrity are important concerns duringcomprehensive cancer care and management of osteoporosis. Bisphosphonates and denosumab are antiresorptive medications widely used for the prevention and treatment of osteoporosis and skeletal complications associated with metastatic cancer and multiple myeloma. Medication-related osteonecrosis of the jaw (MRONJ) related to antiresorptive therapy and chemotherapy is a condition that has created numerous dilemmas in patient management and may have a broad health impact. This case-based presentation will review evidence-based data that has led to paradigm shifts for pathogenesis and innovative strategies for risk assessment, prevention and management of MRONJ.

Dinner will be served!
Located at NYUCD Room 11CF

$20 to attend, $15 for students

Kenneth Fleisher, DDS is a board certified oral and maxillofacial surgeon and a fellow of the American Association of Oral and Maxillofacial Surgery. He is a Clinical Associate Professor in the Department of Oral and Maxillofacial Surgery at the New York University College of Dentistry, Associate Director of the OMS Postgraduate training program and an attending surgeon Bellevue Hospital Center and New York University Langone Medical Center where he participates in training pre-doctoral dental students, postgraduate residents, international residents and faculty on the advancements related to understanding Medication-related osteonecrosis of the jaw (MRONJ).

Dr. Fleisher is recognized by NYU for his clinical expertise in managing patients undergoing antiresorptive therapy and who have developed MRONJ. Dr. Fleisher has treated over 300 patients with MRONJ and has published numerous chapters and papers in peer-reviewed journals, lectures nationally for dental, medical and surgical organizations and he is currently the principal investigator of an interdisciplinary translational research protocol that explores the pathogenesis of osteonecrosis of the jaw.

Dr. Fleisher has developed new strategies for the prevention, diagnosis, risk assessment and treatment of MRONJ. His presentation will focus on the many dilemmas surrounding MRONJ and new strategies to maintain oral health while undergoing antiresorptive therapy.

Share with friends

Date and Time

Location

NYU College of Dentistry

345 East 24th Street

Room 11CF

New York, NY 10010

View Map

Save This Event

Event Saved